Viewing Study NCT05000294


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-01-07 @ 7:55 PM
Study NCT ID: NCT05000294
Status: SUSPENDED
Last Update Posted: 2025-10-15
First Post: 2021-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Sponsor: University of Florida
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module